Member-only story
Pfizer’s COVID Vaccine Gets Excellent Results in Recent Trials
They could seek FDA permission to use it as early as this month
Action films are where you tend to find breakneck timing like this.
The same week that the United States COVID case count is shooting through the roof, a hero comes to save the day. Except neither Will Smith nor Tom Cruise star in this show.
The dynamic duo that may be our salvation is the partnership between US pharmaceutical company Pfizer and its German partner, BioNTech.
They teamed up on a COVID shot that was 90% effective on in the first 94 test subjects. The results are so good in testing that the duo hopes to request FDA permission to sell by the end of November.
To understand what makes their vaccine different, we should first review what a vaccine is.
What is a vaccine?
Vaccines teach the body to battle ailments for which it has little or no immunity. They augment the function of our immune system. Here’s how:
When bacteria slip inside of us and cause trouble, all sorts of alarms go off, white blood cells of different types collaborate, one makes antibodies to fight off the bacteria, for the win.
